Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Revenue: 2023-2025

Historic Revenue for Praxis Precision Medicines (PRAX) over the last 3 years, with Sep 2025 value amounting to $4.4 million.

  • Praxis Precision Medicines' Revenue rose 1365.23% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.3 million, marking a year-over-year increase of 1286.92%. This contributed to the annual value of $8.6 million for FY2024, which is 249.53% up from last year.
  • According to the latest figures from Q3 2025, Praxis Precision Medicines' Revenue is $4.4 million, which was down 10.43% from $4.9 million recorded in Q2 2025.
  • In the past 5 years, Praxis Precision Medicines' Revenue registered a high of $7.5 million during Q4 2024, and its lowest value of $302,000 during Q3 2024.
  • Over the past 3 years, Praxis Precision Medicines' median Revenue value was $683,000 (recorded in 2023), while the average stood at $2.3 million.
  • Per our database at Business Quant, Praxis Precision Medicines' Revenue tumbled by 54.29% in 2024 and then skyrocketed by 1,365.23% in 2025.
  • Praxis Precision Medicines' Revenue (Quarterly) stood at $515,000 in 2023, then soared by 1,349.13% to $7.5 million in 2024, then spiked by 1,365.23% to $4.4 million in 2025.
  • Its Revenue was $4.4 million in Q3 2025, compared to $4.9 million in Q2 2025 and $5.4 million in Q1 2025.